Publications by authors named "Stacey Goodman"

Claim this Profile
D
Daratumumab-Based Treatment for Immunoglobulin Light-Chain Amyloidosis.
Efstathios Kastritis, Giovanni Palladini, Monique C Minnema, Ashutosh D Wechalekar, Arnaud Jaccard, Stacey A Goodman

N Engl J Med· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Bortezomib-Based Induction Is Associated with Superior Outcomes in Light Chain Amyloidosis Patients Treated with Autologous Hematopoietic Cell Transplantation Regardless of Plasma Cell Burden.
Robert F Cornell, Raphael Fraser, Luciano Costa, Stacey Goodman, Noel Estrada-Merly

Transplant Cell Ther· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Similar Outcomes in Early-Failure Steroid-Dependent Compared to Upfront Steroid Refractory Acute Graft-Versus-Host Disease Following Allogeneic Hematopoietic Cell Transplant.
Dilan A Patel, Karina A Mendoza, Heidi Chen, Brian G Engelhardt, Bipin N Savani, Stacey A Goodman

J Hematol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New-onset post-transplant diabetes mellitus after haploidentical hematopoietic cell transplant with post-transplant cyclophosphamide.
Brendan L Mangan, Dilan Patel, Heidi Chen, Katie S Gatwood, Michael T Byrne, Stacey Goodman

EJHaem· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of venetoclax-based salvage therapy for post-hematopoietic cell transplantation relapse of acute myeloid leukemia.
Michael Byrne, Nathalie Danielson, Salyka Sengsayadeth, Adrianne Rasche, Katie Culos, Stacey Goodman

Am J Hematol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes in patients with cardiac amyloidosis and implantable cardioverter-defibrillator.
Eun-Jeong Kim, Benjamin B Holmes, Shi Huang, Ricardo Lugo, Asad Al Aboud, Stacey Goodman

Europace· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Minimal residual disease negativity and lenalidomide maintenance therapy are associated with superior survival outcomes in multiple myeloma.
Dilan A Patel, Ragisha Gopalakrishnan, Brian G Engelhardt, Evonne McArthur, Salyka Sengsayadeth, Stacey Goodman

Bone Marrow Transplant· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tandem Autologous-Autologous versus Autologous-Allogeneic Hematopoietic Stem Cell Transplant for Patients with Multiple Myeloma: Long-Term Follow-Up Results from the Blood and Marrow Transplant Clinical Trials Network 0102 Trial.
Sergio Giralt, Luciano J Costa, David Maloney, Amrita Krishnan, Mingwei Fei, Stacey Goodman

Biol Blood Marrow Transplant· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Study of Cardiac Events During Proteasome Inhibitor Therapy for Relapsed Multiple Myeloma.
Robert F Cornell, Bonnie Ky, Brendan M Weiss, Cherie N Dahm, Deepak K Gupta, Stacey A Goodman

J Clin Oncol· August 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Interaction of Peripheral Blood Lymphocyte Counts (ALC) With Different Depletion Strategies in Predicting Outcomes of Allogeneic Transplant: An International 2 Center Experience.
Vipul Sheth, Vanessa Kennedy, Hugues de Lavallade, Donal Mclornan, Victoria Potter, Stacey Goodman

Front Oncol· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective trial of minimal residual disease assessment by multiparametric flow cytometry for multiple myeloma in the era of bortezomib-based chemotherapy.
C Amos Clark, Claudio A Mosse, Heidi Chen, Michael Byrne, Wichai Chinratanalab, Stacey A Goodman

Bone Marrow Transplant· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subcutaneous scalp nodule as the presenting symptom of systemic light-chain amyloidosis.
Joseph Tadros, Stacey Goodman, Eric R Tkaczyk

Dermatol Pract Concept· July 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes of a novel rituximab-based non-myeloablative conditioning regimen for hematopoietic cell transplantation in severe aplastic anemia.
Katie S Gatwood, Kathryn A Culos, Laura A Binari, Brian G Engelhardt, Adetola Kassim, Stacey A Goodman

Bone Marrow Transplant· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lenalidomide vs bortezomib maintenance choice post-autologous hematopoietic cell transplantation for multiple myeloma.
Jennifer Huang, Sharon Phillips, Michael Byrne, Wichai Chinratanalab, Brian G Engelhardt, Stacey A Goodman

Bone Marrow Transplant· June 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing Antithymocyte Globulin Dosing for Unrelated Donor Allogeneic Hematopoietic Cell Transplantation Based on Recipient Absolute Lymphocyte Count.
Vanessa E Kennedy, Heidi Chen, Bipin N Savani, John Greer, Adetola A Kassim, Stacey Goodman

Biol Blood Marrow Transplant· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Outcomes from Autologous Hematopoietic Cell Transplantation versus Chemotherapy Alone for the Management of Light Chain Amyloidosis.
Oluchi Oke, Tarsheen Sethi, Stacey Goodman, Sharon Phillips, Ilka Decker

Biol Blood Marrow Transplant· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel pathologic scoring tools predict end-stage kidney disease in light chain (AL) amyloidosis.
Samuel Rubinstein, Robert F Cornell, Liping Du, Beatrice Concepcion, Stacey Goodman

Amyloid· September 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The six-minute walk test is a valuable measure of functional change following chemotherapy for AL (light-chain) cardiac amyloidosis.
Ilka Decker, Stacey A Goodman, Sharon E Phillips, Daniel J Lenihan, Robert F Cornell

Br J Haematol· May 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Current Concepts of Cardiac Amyloidosis: Diagnosis, Clinical Management, and the Need for Collaboration.
Alexandra J Ritts, Robert F Cornell, Kris Swiger, Jai Singh, Stacey Goodman

Heart Fail Clin· April 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metabolic Complications Precede Alloreactivity and Are Characterized by Changes in Suppression of Tumorigenicity 2 Signaling.
Romany A N Johnpulle, Sophie Paczesny, Dae Kwang Jung, Etienne Daguindau, Madan H Jagasia, Stacey Goodman

Biol Blood Marrow Transplant· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reduced-Intensity Conditioning with Fludarabine, Cyclophosphamide, and Rituximab Is Associated with Improved Outcomes Compared with Fludarabine and Busulfan after Allogeneic Stem Cell Transplantation for B Cell Malignancies.
Vanessa E Kennedy, Bipin N Savani, John P Greer, Adetola A Kassim, Brian G Engelhardt, Stacey A Goodman

Biol Blood Marrow Transplant· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Th1 immunity promotes immune tolerance and may impair graft-versus-leukemia effect after allogeneic hematopoietic cell transplantation.
Brian G Engelhardt, Sophie Paczesny, Dae Kwang Jung, Etienne Daguindau, Madan Jagasia, Stacey Goodman

Haematologica· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New allergies after cord blood transplantation.
Leigh Ann Vaughan, Mary Vu, Salyka Sengsayadeth, Catherine Lucid, Carey Clifton, Stacey Goodman

Cytotherapy· October 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Superior long-term outcome of patients with early transformation of non-Hodgkin lymphoma undergoing stem cell transplantation.
Nishitha Reddy, Olalekan Oluwole, John P Greer, Stacey Goodman, Brian Engelhardt

Clin Lymphoma Myeloma Leuk· December 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Consolidative therapy with stem cell transplantation improves survival of patients with mantle cell lymphoma after any induction regimen.
Nishitha Reddy, John P Greer, Stacey Goodman, Adetola Kassim, David S Morgan

Exp Hematol· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis